| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| T651192-1mg |
1mg |
期货  |
| |
| T651192-5mg |
5mg |
期货 |
|
| 别名 | 替鲁司特 |
|---|---|
| 英文别名 | 4-(6-Acetyl-3-(3-((4-acetyl-3-hydroxy-2-propylphenyl)thio)propoxy)-2-propylphenoxy)butanoic acid | TIPELUKAST [INN] | TIPELUKAST [USAN] | 4-(6-Acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric acid | D06659 | Butanoic aci |
| 规格或纯度 | ≥99% |
| 英文名称 | Tipelukast |
| 生化机理 | 替鲁司特（KCA 757）是一种硫酸肽类白三烯受体拮抗剂，是一种口服生物型消炎药，用于治疗哮喘。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
Tipelukast (KCA 757) is a sulfidopeptide leukotriene receptor antagonist, an orally bioavailable anti-inflammatory agent and used for the treatment of asthma. In Vitro Tipelukast inhibits the binding of [ 3 H] LTD4 to the LTD4 receptors on pul-monary cell membrane of guinea-pigs (IC 50 = 2.3 μmol). MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Fiftheen min after an aerosolized antigen challenge, and UNDW inhaled 5 min later into the guinea pigs, Tipelukast significantly alters the UNDW-induced bronchoconstriction . Tipelukast (1 and 5 mg/kg) administered intravenously 15 min after antigen challenge reduces the propranolol-induced bronchoconstriction (PIB) in a dose-dependent manner in guinea-pigs. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:LTD 4 6.41 (pA2, In guinea-pigs) LTE 4 6.45 (pA2, In guinea-pigs) |
| 分子类型 | 小分子 |
|---|---|
| IUPAC Name | 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenyl)sulfanylpropoxy]-2-propylphenoxy]butanoic acid |
| INCHI | InChI=1S/C29H38O7S/c1-5-9-23-25(14-12-22(20(4)31)29(23)36-16-7-11-27(32)33)35-17-8-18-37-26-15-13-21(19(3)30)28(34)24(26)10-6-2/h12-15,34H,5-11,16-18H2,1-4H3,(H,32,33) |
| InChi Key | KPWYNAGOBXLMSE-UHFFFAOYSA-N |
| Canonical SMILES | CCCC1=C(C=CC(=C1OCCCC(=O)O)C(=O)C)OCCCSC2=C(C(=C(C=C2)C(=O)C)O)CCC |
| Isomeric SMILES | CCCC1=C(C=CC(=C1OCCCC(=O)O)C(=O)C)OCCCSC2=C(C(=C(C=C2)C(=O)C)O)CCC |
| 关联CAS | 125961-82-2 |
| PubChem CID | 9893228 |
| MeSH Entry Terms | 4-(6-acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric acid;KCA 757;KCA-757;KCA757;MN 001;MN-001;MN001 cpd |
| 分子量 | 530.67 |
| 溶解性 | Ethanol : 1 mg/mL (1.88 mM; Need ultrasonic and warming) |
|---|---|
| 分子量 | 530.700 g/mol |
| XLogP3 | 6.500 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 17 |
| 精确质量Exact Mass | 530.234 Da |
| 单同位素质量Monoisotopic Mass | 530.234 Da |
| 拓扑极表面积Topological Polar Surface Area | 135.000 Ų |
| 重原子数Heavy Atom Count | 37 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 714.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
首页
400-620-6333
